Suppr超能文献

加速与常规角膜交联术的长期疗效比较。

Long-term results of accelerated and conventional corneal cross-linking.

机构信息

Department of Ophthalmology, Oftalmocentro, Porto Alegre, RS, Brazil.

Programa de Pós-Graduação em Ciências Cirúrgicas, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul e Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.

出版信息

Int Ophthalmol. 2020 Oct;40(10):2751-2761. doi: 10.1007/s10792-020-01462-w. Epub 2020 Jun 13.

Abstract

PURPOSE

The aim of this study is to compare the long-term follow-up outcomes of traditional and accelerated corneal cross-linking (CXL) for keratoconus.

METHODS

This retrospective comparative cohort study included patients with keratoconus who underwent corneal cross-linking (CXL) between August 2008 and December 2016. Patients treated before August 2013 underwent the traditional Dresden protocol, and those treated subsequently received the accelerated protocol, i.e., 0.1% riboflavin soaking for 10 min, followed by pulsed UV-A irradiation at 30 mW/cm for 8 min, and a total irradiation power of 7.2 J/cm. The primary outcome was the success rate in halting the disease progression. The postoperative changes in visual acuity, keratometry readings, endothelial cell count and complications following accelerated CXL and conventional CXL were compared.

RESULTS

This study evaluated 113 eyes over a mean follow-up period of 37.61 ± 16.34 months. It was found that 89.6% and 95.7% of the eyes were successfully treated with the traditional and accelerated protocols, respectively (p = 0.239). The corrected-distance visual acuity improved in both groups, but it was significantly better following the accelerated protocol (p = 0.037). Traditional protocol group had more postoperative complications than the accelerated group (8.9% versus 2%), although not reaching statistically significant difference (p = 0.142). There were no significant differences in the topographic (p = 0.122) and refractive (p = 0.570) outcomes.

CONCLUSION

Accelerated CXL and conventional CXL are both safe and effective, and the long-term follow-up showed that the accelerated protocol was similar to the standard one in terms of halting keratoconus and achieving visual outcomes. Because of its potential benefits, the accelerated protocol may be considered for the treatment of progressive keratoconus.

摘要

目的

本研究旨在比较传统和加速角膜交联(CXL)治疗圆锥角膜的长期随访结果。

方法

本回顾性对比队列研究纳入了 2008 年 8 月至 2016 年 12 月期间接受角膜交联(CXL)治疗的圆锥角膜患者。2013 年 8 月之前接受治疗的患者采用传统的德累斯顿方案,随后接受治疗的患者采用加速方案,即 0.1%核黄素浸泡 10 分钟,随后以 30 mW/cm 的脉冲紫外-A 照射 8 分钟,总辐照功率为 7.2 J/cm。主要结局是停止疾病进展的成功率。比较加速 CXL 和传统 CXL 术后视力、角膜曲率读数、内皮细胞计数和并发症的变化。

结果

本研究平均随访 37.61±16.34 个月,共评估了 113 只眼。结果发现,传统方案和加速方案的治疗成功率分别为 89.6%和 95.7%(p=0.239)。两组矫正视力均有所提高,但加速方案组改善更明显(p=0.037)。传统方案组术后并发症发生率高于加速方案组(8.9%比 2%),但差异无统计学意义(p=0.142)。两组在地形学(p=0.122)和屈光(p=0.570)方面无显著差异。

结论

加速 CXL 和传统 CXL 均安全有效,长期随访显示加速方案在阻止圆锥角膜进展和获得视力结果方面与标准方案相似。由于其潜在益处,加速方案可能被考虑用于治疗进展性圆锥角膜。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验